From diagnosis to treatment to long-term outcomes — using rich, linked health data.
At Schain Research, we do exactly that.
We specialize in transforming national health register data from across the Nordic countries into powerful Real-World Evidence (RWE) that drives smarter healthcare decisions.
Why Nordic register data is uniquely powerful:
– Nationwide population coverage
– Longitudinal follow-up over decades
– Seamless linkage across clinical, pharmacy, and administrative data
– High completeness, standardized coding, and minimal loss to follow-up
At Schain Research, we combine this unparalleled data infrastructure with deep epidemiological and statistical expertise to deliver impactful insights across a broad range of disease areas:
– Cancers: Bladder, prostate, colorectal cancer, etc.
– Hematologic malignancies: Leukemia, multiple myeloma, myelofibrosis, etc.
– Immune-mediated conditions: Chronic graft-versus-host disease (cGVHD), warm autoimmune hemolytic anemia, etc.
– Rare diseases: Adrenoleukodystrophy, warm autoimmune hemolytic anemia, myotonic dystrophy, etc.
Through Nordic register-based studies, we transform complex data into clear, actionable evidence by analyzing patient characteristics, diagnostic trajectories, treatment patterns, healthcare resource use, comparative effectiveness, and long-term outcomes.
If you’re looking for a partner with proven RWE capabilities across the Nordic region, Schain Research is ready to help. Explore our previous publications.
